Matches in Nanopublications for { ?s ?p "[Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP13444.RAqBdL6-SPRZr-K207DWd1Y4qdFRzTJZrgKpdHfqEUOSU130_assertion description "[Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP13444.RAqBdL6-SPRZr-K207DWd1Y4qdFRzTJZrgKpdHfqEUOSU130_provenance.
- NP13449.RAiHQioCZ1ywRRIMBazsTkHvdeAVQgy2ngm5TuqsYBA0g130_assertion description "[Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP13449.RAiHQioCZ1ywRRIMBazsTkHvdeAVQgy2ngm5TuqsYBA0g130_provenance.
- assertion description "[Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP12174.RAQZrEpHPG72d3fNz3Zt8zKv5JzNrPYVHBUMWZScUgGFE130_assertion description "[Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP12174.RAQZrEpHPG72d3fNz3Zt8zKv5JzNrPYVHBUMWZScUgGFE130_provenance.
- NP12168.RALzHix_EIgr_P0jvSNQcNFZfUynz0SHsb_azA6I3xXM8130_assertion description "[Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP12168.RALzHix_EIgr_P0jvSNQcNFZfUynz0SHsb_azA6I3xXM8130_provenance.
- NP27467.RAoqE8EXyW8CaM3qhGCinUL5LC-XlDbR5NglwwzIjO04M130_assertion description "[Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27467.RAoqE8EXyW8CaM3qhGCinUL5LC-XlDbR5NglwwzIjO04M130_provenance.
- NP27468.RAmC9gUOj8isJ6FXbBAf-diyTSqBFolUIxpdt0l0qqtFE130_assertion description "[Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27468.RAmC9gUOj8isJ6FXbBAf-diyTSqBFolUIxpdt0l0qqtFE130_provenance.